InspireMD Inc — Quarterly Financial Statistics (NASDAQ:NSPR) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities -5.7 M-6.75 M-8.79 M-8.33 M-8.63 M -32.51 M Cash from investing activities -5.92 M8.24 M1.7 M5.32 M7.55 M 22.82 M Cash from financing activities -965 K1.56 M506 K2.14 M52.93 M 57.13 M Free cash flow -6.12 M-7.06 M-9.15 M-8.91 M-8.96 M -34.08 M

Nouvelles

Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates

Lake Street maintient sa recommandation sur InspireMD, citant la croissance du marché

Lake Street reiterates InspireMD stock rating citing market growth

Le directeur commercial d’InspireMD, Gleason, vend des actions NSPR pour 99k€

InspireMD CCO Gleason sells $99k in NSPR stock

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates

Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates

InspireMD nomme Dr. Peter Soukas au poste de directeur médical

InspireMD appoints Dr. Peter Soukas as chief medical officer

Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates

Stifel reprend la couverture de l’action Beta Bionics avec une recommandation d’achat

Goldman Sachs relève Beta Bionics à l’achat en misant sur la croissance des technologies du diabète